Myovant Sciences Ltd (MYOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||
| Net Income | -53,683 | -18,970 | -1,650 |
| Depreciation Amortization | 1 | N/A | 0 |
| Accounts payable and accrued liabilities | 370 | N/A | N/A |
| Other Working Capital | 5,290 | 1,400 | 220 |
| Other Operating Activity | 47,335 | 17,570 | 1,430 |
| Operating Cash Flow | $-687 | $0 | $0 |
| Cash Flows From Investing Activities | |||
| Investing Cash Flow | $0 | $N/A | $0 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 760 | 0 | 0 |
| Financing Cash Flow | $760 | $N/A | $0 |
| End Cash Position | 73 | N/A | 0 |
| Net Cash Flow | $73 | $0 | $0 |
| Free Cash Flow | |||
| Operating Cash Flow | -687 | 0 | 0 |
| Free Cash Flow | -687 | 0 | 0 |